- Home
- CLDI vs VRME Comparison
CLDI vs VRME Comparison
Compare CLDI & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- VRME
- Stock Information
- Founded
- CLDI 2014
- VRME 1999
- Country
- CLDI United States
- VRME United States
- Employees
- CLDI N/A
- VRME N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- VRME EDP Services
- Sector
- CLDI Health Care
- VRME Technology
- Exchange
- CLDI Nasdaq
- VRME Nasdaq
- Market Cap
- CLDI 8.7M
- VRME 10.0M
- IPO Year
- CLDI N/A
- VRME N/A
- Fundamental
- Price
- CLDI $1.58
- VRME $1.13
- Analyst Decision
- CLDI
- VRME Strong Buy
- Analyst Count
- CLDI 0
- VRME 2
- Target Price
- CLDI N/A
- VRME $1.50
- AVG Volume (30 Days)
- CLDI 161.6K
- VRME 503.8K
- Earning Date
- CLDI 11-11-2025
- VRME 11-11-2025
- Dividend Yield
- CLDI N/A
- VRME N/A
- EPS Growth
- CLDI N/A
- VRME N/A
- EPS
- CLDI N/A
- VRME N/A
- Revenue
- CLDI N/A
- VRME $22,071,000.00
- Revenue This Year
- CLDI N/A
- VRME N/A
- Revenue Next Year
- CLDI N/A
- VRME $5.98
- P/E Ratio
- CLDI N/A
- VRME N/A
- Revenue Growth
- CLDI N/A
- VRME N/A
- 52 Week Low
- CLDI $1.41
- VRME $0.55
- 52 Week High
- CLDI $46.68
- VRME $5.00
- Technical
- Relative Strength Index (RSI)
- CLDI 44.14
- VRME 60.01
- Support Level
- CLDI $1.51
- VRME $1.00
- Resistance Level
- CLDI $1.74
- VRME $1.13
- Average True Range (ATR)
- CLDI 0.10
- VRME 0.09
- MACD
- CLDI 0.04
- VRME 0.01
- Stochastic Oscillator
- CLDI 30.43
- VRME 77.78
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About VRME VerifyMe Inc.
VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.